Oxcias vision is to transform state-of-art science into valuable drugs and health products to improve lives.

Oxcia supports early life science research arising out of academia into drug and/or medical device development and commercialization. The company has strong skills in preclinical and clinical development, business and patent strategies as well as negotiations with potential business partners. Karonudib and Libragel, are prime examples of our oncology drug development and medical device development projects.